There were 122 National Labor Relations Board representation elections run in February 2025, and ten involved units of 250 or ...

A healthcare company targeted by U.S. Rep. Pat Ryan as part of a service probe said that its facilities have undergone much in the way of improvement since it acquired them. In a ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.

Michael Arulfo, CPM, CLP, CSPO, has built a distinguished career at the intersection of enterprise architecture and ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

These changes are part of ongoing efforts to reduce total UnitedHealthcare prior authorization volume," the company said.

Optum said that the company has its own experience in dealing with issues that are not in its control. “We, too, have felt the impact of the national health care provider shortage and are ...

Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...

UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare ...

The global clinical informatics market, valued at US$ 198.33 Billion in 2023, is forecasted to grow at a robust CAGR of 16.0% ...